Cite
HARVARD Citation
Thibodeaux, S. et al. (2023). Assessing deviations for HPCs obtained during COVID‐19 (ADHOC): Evaluating impact of the COVID‐19 pandemic on cellular therapy products and processes, the BEST collaborative study. Transfusion. 63 (4), pp. 782-790. [Online].